June 18, 2026

AI Tool May Cut Macular Edema Referrals

An artificial intelligence–based optical coherence tomography pathway met noninferiority criteria for false-positive diabetic macular edema referrals and was associated with fewer referral decisions in a randomized clinical trial.

Conexiant

June 01, 2026

Nomogram Advances Retinopathy Screening

A simple, data-driven tool could help clinicians identify high-risk patients before vision is threatened

The Ophthalmologist

May 27, 2026

Retinal Age as Disease Biomarker

Fundus-based AI screening can indicate “retinal age” of patients, as well as flag systemic disease risks, says new study

The Ophthalmologist

May 14, 2026

What RVO May Reveal About Systemic Health

TriNetX data presented at Retina World Congress linked BRVO and CRVO with increased risks of stroke, myocardial infarction, and carotid disease.

Retinal Physician

May 13, 2026

Diabetes Risk Scores: Beyond Glucose

Multi-ancestry polygenic models identify high-risk patients traditional screening may miss.

Conexiant

May 11, 2026

Semaglutide Linked to NAION Risk

A retrospective database study found a low absolute incidence but higher relative hazard of ischemic optic neuropathy following semaglutide initiation.

Conexiant

May 05, 2026

AI Boosts Diabetic Eye Care Access

Recent study highlights how integrated AI-assisted DR screening in primary care clinics can improve access and decrease disparity

The Ophthalmologist

May 01, 2026

Steroid Strategies in Diabetic Macular Edema

Retinal Physician

May 01, 2026

Retinal Age Model Tied to Disease Risk

Fundus-based tool estimates biologic aging but shows modest gains over prior models

Conexiant

May 01, 2026

Telemedicine and Retina Care

Retinal Physician